Apolipoprotein J and Alzheimer's amyloid beta solubility

Area of Science:

• Neuroscience
• Biochemistry
• Protein Chemistry

Background:

• Apolipoprotein J (apoJ) is found with amyloid beta (A beta) in biological fluids and brain lesions.
• ApoJ is known as a carrier protein for soluble A beta (sA beta).
• The role of apoJ in A beta fibrillogenesis remains unclear.

Purpose of the Study:

• To investigate the role of apoJ in A beta aggregation and stability.
• To determine if apoJ in its native form can interact with and modify A beta peptides.
• To assess the protective effect of apoJ against A beta degradation.

Main Methods:

• In vitro studies using synthetic A beta peptides and native apoJ.
• Assays to monitor A beta aggregation and polymerization.
• Proteolytic degradation assays using trypsin and chymotrypsin.
• Stability studies of apoJ-A beta complexes.

Main Results:

• Native apoJ effectively interacts with A beta peptides.
• ApoJ prevents the aggregation and polymerization of synthetic A beta in vitro.
• ApoJ-A beta complexes are stable for at least 14 days.
• A beta peptides bound to apoJ exhibit increased resistance to proteolytic degradation.

Conclusions:

• Apolipoprotein J actively interacts with A beta peptides, preventing their aggregation.
• ApoJ binding protects A beta from proteolytic breakdown.
• These findings suggest apoJ may play a crucial role in modulating A beta aggregation in vivo.